AG
SRPT icon

Algert Global’s Sarepta Therapeutics SRPT Stock Holding History

Algert Global’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Buy
64,365
+18,840
+41% +$356K 0.01% 953
2026
Q1 		$991K Sell
45,525
-104,480
-70% -$2.02M 0.01% 865
2025
Q4 		$3.23M Sell
150,005
-201,979
-57% -$4.26M 0.05% 580
2025
Q3 		$6.78M Buy
351,984
+202,074
+135% +$3.6M 0.11% 309
2025
Q2 		$2.56M Buy
149,910
+73,241
+96% +$3.12M 0.05% 556
2025
Q1 		$4.89M Buy
76,669
+1,685
+2% +$177K 0.12% 283
2024
Q4 		$9.12M Buy
74,984
+5,778
+8% +$708K 0.21% 134
2024
Q3 		$8.64M Buy
69,206
+6,654
+11% +$920K 0.23% 108
2024
Q2 		$9.88M Buy
62,552
+795
+1% +$102K 0.33% 44
2024
Q1 		$8M Buy
61,757
+15,238
+33% +$1.87M 0.31% 64
2023
Q4 		$4.49M Buy
46,519
+3,337
+8% +$320K 0.18% 169
2023
Q3 		$5.23M Buy
43,182
+17,670
+69% +$2M 0.25% 105
2023
Q2 		$2.92M Buy
25,512
+4,480
+21% +$578K 0.13% 253
2023
Q1 		$2.9M Sell
21,032
-31,212
-60% -$4.05M 0.14% 226
2022
Q4 		$6.77M Sell
52,244
-8,426
-14% -$976K 0.38% 28
2022
Q3 		$6.71M Buy
60,670
+17,479
+40% +$1.76M 0.41% 10
2022
Q2 		$3.24M Sell
43,191
-3,812
-8% -$280K 0.24% 70
2022
Q1 		$3.67M Buy
47,003
+33,066
+237% +$2.53M 0.24% 78
2021
Q4 		$1.25M Hold
13,937
– – 0.16% 206
2021
Q3 		$1.29M Buy
+13,937
New +$1.07M 0.17% 148
2020
Q3 		– Sell
-6,138
Closed -$984K – 480
2020
Q2 		$984K Buy
+6,138
New +$835K 0.33% 106

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Algert Global's SRPT Position: Q2 2026 in Review

Algert Global increased its Sarepta Therapeutics (SRPT) stake by 41% in Q2 2026, buying an estimated $356K and bringing the position to 64,365 shares worth $1.16M. The position accounts for 0.01% of the portfolio, ranked #953.

Algert Global first reported a position in SRPT in Q2 2020 and has held it in 21 quarters since. The position peaked at $9.88M in Q2 2024. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Algert Global held 64,365 shares of Sarepta Therapeutics worth $1.16M as of Q2 2026.
  • Algert Global bought 18,840 Sarepta Therapeutics shares in Q2 2026, an estimated $356K.
  • Sarepta Therapeutics made up 0.01% of Algert Global's portfolio in Q2 2026, its #953 holding.
  • Algert Global first reported a position in Sarepta Therapeutics in Q2 2020 and has held it in 21 quarters since.
  • Algert Global's Sarepta Therapeutics position peaked at $9.88M in Q2 2024.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.